avapro and nephrin
avapro has been researched along with nephrin in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Allen, TJ; Boner, G; Bonnet, F; Cao, Z; Cooper, ME; Kawachi, H | 1 |
| Long, HB; Wei, LB; Xu, ZZ; Zhong, J; Zhou, WD | 1 |
| Chow, KM; Kwan, BC; Lai, FM; Lai, KB; Li, PK; Szeto, CC; Wang, G | 1 |
| Ferrario, CM; Habibi, J; Hayden, MR; Johnson, MS; Nistala, R; Rehmer, N; Schneider, RI; Sowers, JR; Tilmon, R; Whaley-Connell, A | 1 |
| Dai, HY; Li, Q; Liu, BC; Ma, KL; Ni, J; Tang, RN; Zheng, M | 1 |
| Fukusumi, Y; Kawachi, H; Kayaba, M; Kitazawa, Y; Takahashi, A; Tomita, M; Yamazaki, M | 1 |
| Azegami, T; Hayashi, K; Itoh, H; Nakamura, M; Oguchi, H; Sakamaki, Y; Sasamura, H; Tokuyama, H; Wakino, S | 1 |
Trials
1 trial(s) available for avapro and nephrin
| Article | Year |
|---|---|
Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Diabetic Nephropathies; Drug Therapy, Combination; Female; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Irbesartan; Male; Membrane Proteins; Microfilament Proteins; Middle Aged; Podocytes; RNA, Messenger; Tetrazoles; Treatment Outcome | 2008 |
Other Studies
6 other study(ies) available for avapro and nephrin
| Article | Year |
|---|---|
Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension.
Topics: Albuminuria; Analysis of Variance; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression Regulation; Hypertension; Irbesartan; Male; Membrane Proteins; Oligonucleotide Probes; Proteins; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles | 2001 |
[Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Desmin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Irbesartan; Kidney; Membrane Proteins; Podocytes; Rats; Rats, Sprague-Dawley; Tetrazoles | 2007 |
Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Topics: Albuminuria; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Fumarates; Glomerular Filtration Rate; Hypertension; Irbesartan; Kidney; Membrane Glycoproteins; Membrane Proteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Podocytes; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles; Tyrosine | 2010 |
Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Pressure; Blotting, Western; Desmin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Immunohistochemistry; Irbesartan; Male; Membrane Proteins; Microscopy, Electron; Podocytes; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Time Factors | 2011 |
Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Irbesartan; Kidney Glomerulus; Membrane Proteins; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors | 2014 |
Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cell Line; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Doxorubicin; Epigenesis, Genetic; Irbesartan; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Podocytes; Promoter Regions, Genetic; Renal Insufficiency, Chronic; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Time Factors; Transfection | 2015 |